ResMed (RMD) Misses Q3 EPS by 10c

ResMed (NYSE: RMD) reported Q3 EPS of $1.32, $0.10 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $864.5 million versus the consensus estimate of $897.04 million.

For earnings history and earnings-related data on ResMed (RMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c